Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
107 Cards in this Set
- Front
- Back
GLUCOCORTICOIDS
|
|
|
|
|
|
how does cortisol increase fight or flight response (2)?
|
1) increase epinephrine synthesis; 2) increase sensitivity of tissues to catecholamines
|
|
what four problems will sustained increase in glucocorticoids cause?
|
1) diabetes (from counter-regulation of glucose); 2) CV effects; 3) osteoporosis; 4) (increased bone resorption, decreased Ca++ absorption)
|
|
what is a synthetic CRH, and what is it used for clinically?
|
cosyntropin, a synthetic CRH, is used to diagnose Cushing's disease
|
|
in what pattern is GC synthesis secreted?
|
diurnal
|
|
what enzymes mediate the direct genomic effects of GC action (3)?
|
1) tyrosine aminotransferase (AA degradation); 2) phosphoenolpyruvate carboxykinase; 3) G-6-Phosphatase - last two involved in gluconeogenesis - dysregulation leads to diabetes
|
|
how do indirect genomic effects work?
|
GR binds to DNA binding proteins like NFkB and inhibits their ability to upregulate genes
|
|
what type of genes are downregulated?
|
those that stimulate inflammatory response - cytokines like IL-8, 12, and TNF-a
|
|
what are indirect genomic effects initiated by, and what are they important for?
|
interactions with membrane bound or cytoplasmic GRs, or interactions with cell membrane - important for eliciting changes in vascular tone
|
|
what actions occur first, genomic or nongenomic?
|
nongenomic - they occur very fast
|
|
what is the treatment for glucocorticoids increasing bone loss through interference with Ca++ uptake and vitamin D actions, in adults?
|
administration of oral bisphosphonate, Ca++, vitamin D
|
|
what hormones do GCs inhibit production of, that relate to growth and development?
|
sex steroids
|
|
what do excessive amounts of GCs or MCs do to muscle/skeleton?
|
can impair muscle, and cause skeletal wasting
|
|
why can large GC doses lead to ulcers?
|
suppress immune response against H. pylori
|
|
what is normal treatment for glucocorticoid insufficiency?
|
hydrocortisone
|
|
what is added if it is Addison's (both inner and outer zone destroyed)?
|
hydrocortisone + fludrocortisone
|
|
what drugs (3) can pharmacologically reduce cortisol synthesis (3)?
|
1) ketoconazole; 2) aminogluthemide; 3) metapyrone
|
|
|
|
|
GLUCOCORTICOIDS AND INNATE IMMUNE RESPONSE
|
|
|
|
|
|
how do glucocorticoids affect cell trafficking and adhesion molecules in innate immune response?
|
alter bone marrow release and infiltration and clearance of leukocytes, decrease expression of adhesion molecules, decrease chemokine release at inflammation site
|
|
in what disease do glucocorticoids prevent inflammatory response from overshooting?
|
meningitis
|
|
what cells do they promote survival and proliferation of, and what cells do they induce apoptosis of (innate IR)?
|
promote survival of neutrophils, induce apoptosis of eosinophils
|
|
in what case are glucocorticoids used to prevent inflammatory response from overshooting, and how does this work on phagocytes?
|
enhance clearance of foreign antigens, toxins, microbes, enhance opsonization, stimulate macrophages to phagocytose
|
|
how does this affect cytokines?
|
increase antiinflammatory, decrease proinflammatory
|
|
how do glucocorticoids affect biochemical mediators of inflammation?
|
block release of arachadonic acid and thus formation of prostaglandins, thromboxanes, and leukotrienes, decrease NO release, decrease formation of free radicals
|
|
|
|
|
ADAPTIVE/CELLULAR/HUMORAL IMMUNE RESPONSE
|
|
|
|
|
|
formation of what particular cell is blocked that may lead to cellular immunodeficiency?
|
Th1 helper T cell
|
|
how are dendritic cells affected?
|
can't present antigens as well or mature as well
|
|
formation of what cell is increased by glucocorticoids, and what is the result?
|
Th2 helper cell - stimulates humoral immune response and increased antibody formation
|
|
what may be the underlying mechanism of steroid resistant asthma and ulcerative colitis?
|
administration of GCs will increase IgE levels
|
|
what do glucocorticoids do to B cells and why is this useful?
|
inhibit proliferation and development, useful for leukemia
|
|
how else do glucocorticoids relate to IgE secretion?
|
prevent the release of IgE-R mediated release of inflammatory mediators, and also deplete tissue mucosal mast cells
|
|
what AE can glucocorticoids cause in the eye?
|
cataracts
|
|
what is a recently developed drug in glucocorticoid therapy, how does it function, what is it used for, and what are its advantages?
|
ZK 216348 - binds GR with high affinity, represses inflammatory response, and does not appear to induce side effects such as thinning of skin and increased glucose
|
|
|
|
|
GLUCOCORTICOID DRUGS AND TREATMENTS
|
|
|
|
|
|
how is dose usually determined in glucocorticoid treatment?
|
trial and error
|
|
what can happen after abrupt cessation after long term use?
|
adrenal insufficiency (may be fatal)
|
|
what is alternate dose therapy and when is it used?
|
GC may suppress allergic phenomena when given every 48 hours, whereas pituitary suppression is shorter lived
|
|
what iGC is used for asthma and why?
|
flucitasone, because it is highly metabolized
|
|
what is an example of a GC given intravenously?
|
hydrocortisone Na++ succinate
|
|
what is a long acting type of GC?
|
intraarticular injection of crystalline, insoluble GC
|
|
what are the features of pulmonary and dermal administration both (2)?
|
high potency, limited systemic effect
|
|
what drug regimen with GCs is most effective for asthma?
|
inhaled GC coadministered with inhaled beta-2 agonists
|
|
what were said not to be considered significant risks for children (4)?
|
decreased growth, decreased bone mineral density, suppressed adrenal glands, cataracts (but height of children should be monitored)
|
|
what drugs must we know are sued for asthma (2)?
|
1) beclomethasone; 2) flucitasone
|
|
what drugs are used for allergic rhinitis (2), how are they given, and which has higher potency?
|
given as nasal spray - 1) beclomethasone (high potency); 2) triamcinolone (medium potency)
|
|
what are pros and cons of treating allergic rhinitis with GCs?
|
broad relief of symptoms, low systemic absorption, but adverse effects
|
|
what drugs are typically given topically for eczema and psoriasis (2)?
|
1) hydrocortisone; 2) betamethasone
|
|
what drug is given as an intralesional injection?
|
triamcinolone acetonide
|
|
what is done for acute eczematous reaction such as poison oak?
|
systemic therapy with prednisone, tapered over 21 days
|
|
what is the goal of GC therapy for MS?
|
ameliorate suffering during attacks (6 weeks)
|
|
what GC drugs are given for MS and how is each administered (2)?
|
1) prednisone oral tapering course; 2) methylprednisone IV for 3-5 days
|
|
what drugs are given for allograft rejection (2)?
|
prednisone, methylprednisone
|
|
what drug is typically given for rheumatic diseases, and what other drugs are used with it (non GC - 2)?
|
prednisolone - also NSAID and disease modifying drug
|
|
what happens to the GC, eventually, and over how long?
|
weaning, over as much as two years
|
|
what type of therapy is often given for RA with methylprednisone?
|
pulse therapy IV ofer 3-7 days
|
|
what GC drug is given as a joint injection for RA?
|
triamcinolone acetonide
|
|
what are GCs able to do for RA?
|
decrease pain/disability/inflammation in first year but not sure about long term efficacy, does not alter structural damage
|
|
what are side effects of treating RA with GCs (2)?
|
1) osteoporosis; 2) ulcers
|
|
in what case are GCs used in Crohn's disease, what drug is used, and why?
|
in patients who do not respond to conservative management - oral budesonide is used because it is better tolerated and more effective than prednisolone
|
|
what should be remembered about pharmacokinetics of oral budesonide?
|
11% bioavailability because it dissolves in ileum and ascending colon due to pH
|
|
what malignancy are GCs particularly used for (to induce apoptosis), and what GCs are used (3)?
|
lymphoid malignancies, namely ALL - drugs used: 1) prednisone; 2) methylprednisone; 3) dexamethasone
|
|
how else is it useful in cancer (2)?
|
potentiates effeccts of other cytotoxic agents (prednisone/vincristine/doxorubicin/cyclophosphamide for non-Hodgkin's), also treats complications associated with cancer (cerebral edema, pain)
|
|
what GC drug regimen is used in tuberculous meningitis?
|
prednisone for first month
|
|
what drug is a mineralocorticoid receptor antagonist, and what does it do?
|
spironolactone - reduces the expression of gene controlling synthesis of Na/K ATPase
|
|
what drug is an antagonist of glucocorticoid receptors, and what is it used for (2)?
|
RU 486 (Mifepristone) - used in: 1) Cushing's; 2) abortion
|
|
what drug inhibits the initial and rate-limiting step in the biosynthesis of all physiological steroids?
|
aminogluthemide
|
|
what is it used for (in conjunction with other drugs)?
|
to treat steroid producing adrenocortical tumor
|
|
what drug inhibits the terminal step in GC synthesis (11-B hydroxylase) and what is this drug used for?
|
metyrapone - used in diagnostic test of adrenal function
|
|
what drug can block all teroidogenesis and can be used for hirsutism, adrenal carcinomas, and breast cancer?
|
ketoconazole
|
|
in what diseases is glucocorticoid resistance the most problematic (2)?
|
asthma, ALL (5% of patients have no response to 7 day therapy with prednisone)
|
|
what are three new therapeutic develpments with GCs?
|
1) develop drugs with transrepression >> transactivation (flucitasone pripionate, RU486, other RU's); 2) develop drugs that specifically inhibit NFkB or TNF (i.e. infliximab for RA); 3) develop retinoic acid derivatives (synergistic actions between RXR and GR)
|
|
|
|
|
MINERALOCORTICOIDS
|
|
|
|
|
|
what genes are directly regulated by aldosterone (2)?
|
1) CHIF - challen inducing factor; 2) epithelial sodium channel subunits
|
|
what were said to directly regulate the Na/K ATPase genes?
|
glucocorticoids such as dexamethasone
|
|
how strongly does aldosterone activate the MR compared to cortisol?
|
equal affinity
|
|
how do MR and GR compare as far as their ability to activate gene transcription via hormone response element?
|
stimulate it equvalently
|
|
how is specificity gained?
|
by location of MR and GR
|
|
where is the GR located, and where is the MR (5)?
|
GR - all cells; MR - kidney, gut, sweat glands, brain, and vascular smooth muscle
|
|
how else do they differ?
|
differential transcriptional activation
|
|
what key enzyme is expressed only in some mineralocorticoid responsive tissues?
|
11B-hydroxysteroid dehydrogenase type 2 (11B-HSD)
|
|
what are the two main strategies for treating mineralocorticoid excess, and what drug(s) is used for each?
|
1) antagonize mineralocorticoid receptor (spironolactone); 2) antagonize Na+ exchange in distal nephrone (amiloride, triamterene)
|
|
what happens when there is high concentrations of spironolactone?
|
inhibits androgen receptor
|
|
what other problems may spironolactone cuase (2)?
|
1) hyperchloremic acidosis; 2) hypokalemia
|
|
how is mineralocorticoid deficiency treated, and what is the affinity of this drug for MR and GR?
|
flucortisone - 10x affinity for MR compared to GR
|
|
what are side effects of flucortisone, and what should be monitored?
|
hypertension, hypokalemia - monitor BP and renin activity
|
|
what is the treatment for CAH (21-hydroxylase or 17-hydroxyprogesterone deficiency) (2)?
|
1) fludrocortisone; 2) hydrocortisone (GC)
|
|
what is the treatment for primary aldosteronism?
|
unilateral adrenalectomy
|
|
what is the treatment for pseudohypoaldosteronism (a rare form of mineralocorticoid resistance that presents as neonatal renal salt wasting, caused by mutations in mineralocorticoid receptor)?
|
sodium supplementation
|
|
what is the treatment for apparent mineralocorticoid excess (3)?
|
1) amiloride and/or spironolactone; 2) antihypertensive; 3) KCl supplements
|
|
what mutation can cause pregnancy induced hypertension, and why?
|
missense mutation (L810) in ligand binding domain of MR allows a number of steroids to act as MR agonists
|
|
what else can act as an agonist, and what does it cause?
|
spironolactone can act as an agonist, and allow constitutive activity of MR
|
|
what MR antagonist is more preferred than spironolactone, and why?
|
eplenerone - it is more selective (but has lower affinity for MR)
|
|
what are the three high potency GC agonists?
|
1) beclomethasone; 2) betamethasone; 3) dexamethasone
|
|
what are the three mid potency GC agonists?
|
1) methylprednisone; 2) prednisolone; 3) prednisone
|
|
what are three inhibitors of cortisol synthesis?
|
1) metyrapone; 2) ketoconazole; 3) aminoglutethimide
|
|
what MR agonist must we know?
|
fludrocortisone
|
|
what MR antagonists must we know (2)?
|
1) spironolactone; 2) eplenerone
|
|
|
|